查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2088416

細胞分選市場：2026-2032年全球市場預測（依產品、檢體技術、樣品來源、應用及最終用戶分類）

Cell Sorting Market by Product Offering, Sorting Technology, Sample Source, Application Area, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，細胞分選市場規模將達到 30.7 億美元，複合年成長率為 8.79%。

主要市場統計數據
基準年 2025 17億美元
預計年份：2026年 18.5億美元
預測年份 2032 30.7億美元
複合年成長率 (%) 8.79%

細胞分選市場執行摘要

細胞分選市場正從專業的實驗室工作流程轉向精準醫療、免疫腫瘤學、幹細胞研究、感染疾病監測和生物製造等領域的策略基礎。螢光活化細胞分選 (FACS)、磁活化細胞分選 (MACS)、微流體細胞分選以及新興的無標定平台等技術正在推動市場需求，這些技術使研究人員能夠以更高的純度、更強的處理能力和更高的可重複性分離出活細胞群。

細胞分選領域的變革性變化

細胞分選領域正經歷一場變革，從依賴人工操作的手動流程轉向自動化、標準化和數據驅動的工作流程。高參數流式細胞技術、頻譜細胞儀、盒式的微流體技術、成像分選以及無菌密封系統正在改變學術機構、受託研究機構(CRO)、診斷公司和生物製藥企業處理稀有且脆弱細胞的方式。

人工智慧對細胞分選的累積影響

人工智慧 (AI) 透過改進設門、異常檢測、事件分類、實驗設計和儀器維護，對整個細胞分選領域產生了累積的影響。 AI 驅動的流式細胞技術分析可以減少數據解讀中操作者的差異，而數據解讀差異一直是高維度免疫表現型分析、稀有細胞鑑定和縱向免疫監測中長期存在的挑戰。

對關鍵區域的洞察

亞太地區正迅速發展，中國、印度、日本、澳洲和韓國都在增加對生物技術、癌症研究、疫苗平台和先進療法製造的投資。中國完善的生物製藥生態系統和醫院附屬研究網路正在滿足對高通量流式細胞技術和磁性細胞分選的需求，而印度則受益於其不斷完善的臨床研究基礎設施、公共生物技術舉措和低成本的生命科學服務。日本、澳洲和韓國則透過強大的學術研究、再生醫學計畫、精準腫瘤學以及生技藥品製造能力做出貢獻。

關鍵小組洞察

東協地區的需求得益於新加坡、泰國、馬來西亞、印尼、越南和菲律賓不斷增強的生物醫學研究能力，其中新加坡已成為生物製藥研發、轉化醫學和臨床研究的區域中心。海灣合作理事會（GCC）國家正在投資精準醫療、癌症治療、基因組學、醫院現代化和專業實驗室基礎設施，為先進的流式細胞技術、磁分離和封閉式細胞處理系統創造了獨特的機會。

主要國家的概況

美國憑藉對生物製藥的大規模投資、美國國立衛生研究院（NIH）支持的免疫學和腫瘤學研究、積極的臨床試驗活動以及緊密的大學附屬醫療中心網路（這些中心利用流式細胞術（FACS）、磁共振流式細胞術（MACS）、頻譜流式細胞術和單細胞分析等技術），在全球生物技術應用方面處於領先地位。加拿大在幹細胞科學、免疫學和轉化醫學領域展現出強大的實力，而墨西哥則憑藉臨床檢查室、學術研究和診斷技術的擴張以及接近性與北美生命科學供應鏈的地理優勢，正迅速崛起。巴西則透過腫瘤學、感染疾病、疫苗研究和公共研究機構，為拉丁美洲地區的需求提供支持。

為行業領導者提供的實用建議

產業領導者應優先考慮自動化程度、細胞存活率、生物安全性和合規性文件，因為買家越來越注重整個工作流程的價值，而不僅僅是設備的規格參數。能夠將高純度分選與直覺易用的軟體、經過驗證的耗材、運轉率的服務、操作人員培訓以及與實驗室資訊管理系統 (LIMS) 和電子實驗室記錄系統整合相結合的供應商，將在監管嚴格和轉化醫學領域擁有顯著優勢。

調查方法

本執行摘要基於一套系統的二級研究框架，該框架利用了公開且檢驗的資訊來源，包括監管出版刊物、臨床試驗註冊資訊、政府研究津貼資訊、同行評審的科學文獻、專利出版物、標準指南和生命科學行業文件。市場分析涵蓋了流式細胞儀（FACS）、微流控分選（MACS）、微流體選、成像分選、頻譜細胞儀和無標定方法等技術的應用。

結論

細胞分選正成為精準生物學、先進療法和高解析度細胞分析的重要基礎。市場發展方向主要受自動化、人工智慧驅動的分析、無菌處理、活細胞回收以及將複雜的細胞數據轉化為可靠的研究和臨床決策等需求驅動。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 細胞分選市場：依產品分類

  • 裝置
    • 細胞分選儀
    • 微流體分選系統
    • 選擇模組和升級
  • 試劑和試劑盒
    • 抗體
    • 磁珠
    • 緩衝液和培養基
    • 存活率染色劑和染色試劑
  • 消耗品
  • 軟體
  • 服務
    • 合約細胞分選
    • 維護和支援
    • 培訓和方法開發

第8章 細胞分選市場：依分選技術分類

  • 聲學細胞分選
  • 螢光活化細胞選擇
  • 成像細胞分選
  • 細胞的磁激活
    • 列式
    • 無列
  • 微流體細胞分選
  • 特殊排序
    • 雷射捕獲顯微切割
    • 拉曼啟動分選

第9章 細胞分選市場：依樣本來源分類

  • 血
    • 全血
    • 周邊血單核細胞（PBMC）
  • 骨髓
  • 固態組織
    • 腫瘤組織
    • 正常組織
  • 細胞培養
    • 原代細胞
    • 細胞株
    • 類器官和球狀體
  • 微生物樣本
    • 細菌
    • 酵母和真菌

第10章 細胞分選市場：依應用領域分類

  • 生命科學概覽
    • 免疫學
    • 腫瘤學
    • 幹細胞生物學
    • 神經科學
  • 臨床診斷
    • 免疫表現型分析
    • 骨髓惡性腫瘤
    • 免疫療法
  • 細胞療法和再生醫學
  • 藥物發現
    • 目標識別與檢驗
    • 篩檢及先導藥物最適化
  • 單細胞體學

第11章 細胞分選市場：依最終用戶分類

  • 學術研究機構
  • 製藥和生物技術公司
  • 受託研究機構
  • 醫院和診所

第12章 細胞分選市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章 細胞分選市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 細胞分選市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Becton, Dickinson and Company
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific Inc.
  • Bio-Techne Corporation
  • Sino Biological, Inc.
  • Cytonome/St, LLC by STgenetics group
  • RayBiotech Life, Inc.
  • Menarini Silicon Biosystems SpA
  • Cytek Biosciences, Inc.
  • XIAMEN TOB NEW ENERGY TECHNOLOGY Co., LTD
  • Sony Biotechnology Inc.
  • Akadeum Life Sciences, Inc.
  • Miltenyi Biotec BV & Co. KG
  • NanoCellect Biomedical
  • On-Chip Biotechnologies Co., Ltd.
  • Sepmag Systems, SL
  • Sphere Fluidics Limited
  • Sysmex Partec GmbH
  • uFluidix LLC
  • Union Biometrica, Inc.
Product Code: MRR-034230D3E62D

The Cell Sorting Market is projected to grow by USD 3.07 billion at a CAGR of 8.79% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.70 billion
Estimated Year [2026] USD 1.85 billion
Forecast Year [2032] USD 3.07 billion
CAGR (%) 8.79%

Cell Sorting Market Executive Summary

The cell sorting market is moving from a specialized laboratory workflow to a strategic enabler of precision medicine, immuno-oncology, stem cell research, infectious disease surveillance, and biomanufacturing. Demand is being led by fluorescence-activated cell sorting (FACS), magnetic-activated cell sorting (MACS), microfluidic cell sorting, and emerging label-free platforms that help researchers isolate viable cell populations with higher purity, throughput, and reproducibility.

Growth is supported by measurable expansion in cell and gene therapy pipelines, wider use of single-cell analysis, and sustained public funding for biomedical research through agencies such as the NIH, the European Commission, and national science foundations. As laboratories seek faster turnaround, lower sample loss, and compliant data handling, vendors are competing on automation, closed-system processing, biosafety, software intelligence, and service reliability.

Transformative Shifts in the Cell Sorting Landscape

The cell sorting landscape is being reshaped by the shift from manual, operator-dependent processes toward automated, standardized, and data-rich workflows. High-parameter flow cytometry, spectral cytometry, cartridge-based microfluidics, imaging-enabled sorting, and sterile closed systems are changing how academic centers, contract research organizations, diagnostics developers, and biopharmaceutical manufacturers process rare and sensitive cells.

A second structural shift is the movement of cell sorting from discovery research into translational and GMP-adjacent environments. This raises requirements for traceability, sterility assurance, calibration, sample viability, biosafety, and regulatory documentation, especially where sorted cells are used in CAR-T development, regenerative medicine, immunophenotyping, and companion diagnostic research.

Cumulative Impact of Artificial Intelligence in Cell Sorting

Artificial intelligence is becoming a cumulative force across cell sorting by improving gating, anomaly detection, event classification, experiment design, and instrument maintenance. AI-assisted flow cytometry analysis can reduce inter-operator variability in data interpretation, a persistent challenge in high-dimensional immunophenotyping, rare-cell identification, and longitudinal immune monitoring.

The strongest impact is emerging where AI is integrated with spectral cytometry, imaging flow cytometry, and single-cell multi-omics. These systems generate complex datasets that benefit from machine learning models capable of identifying subtle phenotypes, accelerating target validation, improving quality control, and supporting more consistent decision-making in clinical research and bioprocess development.

Key Regional Insights

Asia-Pacific is expanding rapidly as China, India, Japan, Australia, and South Korea invest in biotechnology, cancer research, vaccine platforms, and advanced therapy manufacturing. China's biopharma ecosystem and hospital-linked research networks support demand for high-throughput flow cytometry and magnetic cell sorting, while India benefits from a growing clinical research base, public biotechnology initiatives, and lower-cost life science services. Japan, Australia, and South Korea contribute through strong academic research, regenerative medicine programs, precision oncology initiatives, and biologics manufacturing capabilities.

North America remains the most mature region due to the United States' large NIH-funded research base, extensive biopharmaceutical R&D, strong clinical trial activity, and early adoption of cell therapy workflows, while Canada supports demand through immunology, oncology, and stem cell research clusters. Europe benefits from European Union research programs, advanced academic hospitals, and established life science manufacturing in Germany, France, the United Kingdom, Italy, and Spain, supported by strong regulatory emphasis on quality and traceability. Latin America, led by Brazil and Mexico, is developing through public health research, academic laboratories, infectious disease monitoring, and private diagnostics investment. The Middle East, particularly GCC countries, is building biomedical infrastructure through national healthcare transformation plans, genomics programs, and cancer care modernization, while Africa's opportunity is linked to infectious disease research, capacity building, workforce training, and regional laboratory modernization.

Key Group Insights

ASEAN demand is supported by expanding biomedical research capacity in Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines, with Singapore serving as a regional hub for biopharma R&D, translational medicine, and clinical research. The GCC is investing in precision medicine, cancer care, genomics, hospital modernization, and specialized laboratory infrastructure, creating selective opportunities for advanced flow cytometry, magnetic separation, and closed cell processing systems.

The European Union provides a strong regulatory, research, and funding environment for collaborative science, workflow standardization, advanced therapy development, and cross-border biomedical innovation. BRICS countries represent a high-volume growth base because Brazil, Russia, India, China, and South Africa combine large patient populations with expanding biomedical infrastructure, public health priorities, and rising biotechnology capabilities. G7 markets continue to lead in innovation, instrument adoption, clinical translation, and high-complexity research workflows, while NATO member countries reinforce demand through biomedical defense, infectious disease preparedness, biosecurity research, and resilient laboratory infrastructure.

Key Country Insights

The United States leads global adoption through deep biopharma investment, NIH-backed immunology and oncology research, strong clinical trial activity, and a dense network of academic medical centers using FACS, MACS, spectral cytometry, and single-cell analysis. Canada shows strength in stem cell science, immunology, and translational medicine, while Mexico is gaining traction through clinical laboratories, academic research, diagnostics expansion, and proximity to North American life science supply chains. Brazil anchors Latin American demand through oncology, infectious disease, vaccine research, and public research institutions.

In Europe, the United Kingdom remains influential in genomics, cell therapy trials, and academic-industry collaboration; Germany combines engineering strength with bioprocessing, diagnostics, and laboratory automation demand; France supports immunology, oncology, and biomedical research; Italy and Spain are expanding hospital-based research, translational medicine, and clinical diagnostics; and Russia maintains capabilities in biomedical science despite supply-chain and geopolitical constraints. In Asia-Pacific, China is scaling biopharma and cell therapy research at speed, India is broadening access to advanced laboratory platforms and clinical research infrastructure, Japan is strong in regenerative medicine and high-quality instrumentation adoption, Australia supports robust clinical research and immunology programs, and South Korea is advancing biologics, diagnostics, and cell therapy manufacturing.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize automation, viability preservation, biosafety, and compliance-ready documentation because buyers increasingly evaluate cell sorting platforms on total workflow value rather than instrument specifications alone. Vendors that combine high-purity sorting with intuitive software, validated consumables, service uptime, operator training, and integration into LIMS or electronic laboratory records will be better positioned in regulated and translational settings.

Strategically, companies should build regional application support, develop AI-enabled analytics partnerships, and create offerings for both premium research centers and cost-sensitive emerging markets. Investment in closed-system sorting, sterile disposable cartridges, spectral data analysis, preventive maintenance, and training programs can help suppliers capture demand from cell therapy developers, CROs, hospitals, biomanufacturers, and academic laboratories.

Research Methodology

This executive summary is based on a structured secondary-research framework using publicly available and verifiable sources, including regulatory agency publications, clinical trial registries, government research funding information, peer-reviewed scientific literature, patent publications, standards guidance, and life science industry documentation. Market interpretation considers technology adoption across FACS, MACS, microfluidic sorting, imaging-enabled sorting, spectral cytometry, and label-free approaches.

The analysis triangulates demand indicators such as biomedical R&D intensity, cell and gene therapy activity, oncology and immunology research output, laboratory infrastructure, clinical trial concentration, public health priorities, and regional healthcare investment. Findings are presented to support strategic planning while avoiding unsupported market-size claims, market share statements, or unverified forecasts.

Conclusion

Cell sorting is becoming an essential infrastructure layer for precision biology, advanced therapeutics, and high-resolution cellular analysis. The market's direction is defined by automation, AI-assisted analytics, sterile processing, viable cell recovery, and the need to translate complex cellular data into reliable research and clinical decisions.

Organizations that align product development, regional expansion, and service models with these trends can capture durable opportunities. The strongest competitive positions will come from combining scientific performance with workflow simplicity, regulatory awareness, data integrity, application support, and scalable service coverage across mature and emerging life science markets.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Cell Sorting Market, by Product Offering

  • 7.1. Instruments
    • 7.1.1. Cell Sorters
    • 7.1.2. Microfluidic Sorting Systems
    • 7.1.3. Sorting Modules And Upgrades
  • 7.2. Reagents And Kits
    • 7.2.1. Antibodies
    • 7.2.2. Magnetic Beads
    • 7.2.3. Buffers And Media
    • 7.2.4. Viability Dyes And Stains
  • 7.3. Consumables
  • 7.4. Software
  • 7.5. Services
    • 7.5.1. Contract Cell Sorting
    • 7.5.2. Maintenance And Support
    • 7.5.3. Training And Method Development

8. Cell Sorting Market, by Sorting Technology

  • 8.1. Acoustic Cell Sorting
  • 8.2. Fluorescence Activated Cell Sorting
  • 8.3. Imaging Cell Sorting
  • 8.4. Magnetic Activated Cell Sorting
    • 8.4.1. Column-Based
    • 8.4.2. Column-Free
  • 8.5. Microfluidic Cell Sorting
  • 8.6. Specialty Sorting
    • 8.6.1. Laser Capture Microdissection
    • 8.6.2. Raman-Activated Sorting

9. Cell Sorting Market, by Sample Source

  • 9.1. Blood
    • 9.1.1. Whole Blood
    • 9.1.2. Peripheral Blood Mononuclear Cells (PBMCs)
  • 9.2. Bone Marrow
  • 9.3. Solid Tissue
    • 9.3.1. Tumor Tissue
    • 9.3.2. Normal Tissue
  • 9.4. Cell Culture
    • 9.4.1. Primary Cells
    • 9.4.2. Cell Lines
    • 9.4.3. Organoids And Spheroids
  • 9.5. Microbial Samples
    • 9.5.1. Bacteria
    • 9.5.2. Yeast And Fungi

10. Cell Sorting Market, by Application Area

  • 10.1. Life Science Research
    • 10.1.1. Immunology
    • 10.1.2. Oncology
    • 10.1.3. Stem Cell Biology
    • 10.1.4. Neuroscience
  • 10.2. Clinical Diagnostics
    • 10.2.1. Immunophenotyping
    • 10.2.2. Hematologic Malignancies
    • 10.2.3. Immune Monitoring
  • 10.3. Cell Therapy And Regenerative Medicine
  • 10.4. Drug Discovery
    • 10.4.1. Target Identification And Validation
    • 10.4.2. Screening And Lead Optimization
  • 10.5. Single-Cell Omics

11. Cell Sorting Market, by End User

  • 11.1. Academic And Research Institutes
  • 11.2. Pharmaceutical & Biotechnology Companies
  • 11.3. Contract Research Organizations
  • 11.4. Hospitals & Clinics

12. Cell Sorting Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Cell Sorting Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Cell Sorting Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Becton, Dickinson, and Company
  • 16.2. Danaher Corporation
  • 16.3. Bio-Rad Laboratories, Inc.
  • 16.4. Thermo Fisher Scientific Inc.
  • 16.5. Bio-Techne Corporation
  • 16.6. Sino Biological, Inc.
  • 16.7. Cytonome/St, LLC by STgenetics group
  • 16.8. RayBiotech Life, Inc.
  • 16.9. Menarini Silicon Biosystems SpA
  • 16.10. Cytek Biosciences, Inc.
  • 16.11. XIAMEN TOB NEW ENERGY TECHNOLOGY Co., LTD
  • 16.12. Sony Biotechnology Inc.
  • 16.13. Akadeum Life Sciences, Inc.
  • 16.14. Miltenyi Biotec B.V. & Co. KG
  • 16.15. NanoCellect Biomedical
  • 16.16. On-Chip Biotechnologies Co., Ltd.
  • 16.17. Sepmag Systems, SL
  • 16.18. Sphere Fluidics Limited
  • 16.19. Sysmex Partec GmbH
  • 16.20. uFluidix LLC
  • 16.21. Union Biometrica, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CELL SORTING MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL CELL SORTING MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL CELL SORTING MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL CELL SORTING MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL CELL SORTING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL CELL SORTING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL CELL SORTING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL CELL SORTING MARKET SIZE, BY PRODUCT OFFERING, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL CELL SORTING MARKET SIZE, BY PRODUCT OFFERING, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CELL SORTING MARKET SIZE, BY SORTING TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL CELL SORTING MARKET SIZE, BY SORTING TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CELL SORTING MARKET SIZE, BY SAMPLE SOURCE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL CELL SORTING MARKET SIZE, BY SAMPLE SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL CELL SORTING MARKET SIZE, BY APPLICATION AREA, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL CELL SORTING MARKET SIZE, BY APPLICATION AREA, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL CELL SORTING MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL CELL SORTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL CELL SORTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL CELL SORTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL CELL SORTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL CELL SORTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL CELL SORTING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL CELL SORTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CELL SORTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CELL SORTING MARKET SIZE, BY PRODUCT OFFERING, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CELL SORTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CELL SORTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CELL SORTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MICROFLUIDIC SORTING SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MICROFLUIDIC SORTING SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MICROFLUIDIC SORTING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SORTING MODULES AND UPGRADES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SORTING MODULES AND UPGRADES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SORTING MODULES AND UPGRADES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL REAGENTS AND KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL REAGENTS AND KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL REAGENTS AND KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ANTIBODIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANTIBODIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ANTIBODIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MAGNETIC BEADS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MAGNETIC BEADS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MAGNETIC BEADS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BUFFERS AND MEDIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BUFFERS AND MEDIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BUFFERS AND MEDIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL VIABILITY DYES AND STAINS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL VIABILITY DYES AND STAINS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL VIABILITY DYES AND STAINS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CONSUMABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CONSUMABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CONTRACT CELL SORTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CONTRACT CELL SORTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CONTRACT CELL SORTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MAINTENANCE AND SUPPORT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MAINTENANCE AND SUPPORT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MAINTENANCE AND SUPPORT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL TRAINING AND METHOD DEVELOPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL TRAINING AND METHOD DEVELOPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL TRAINING AND METHOD DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CELL SORTING MARKET SIZE, BY SORTING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ACOUSTIC CELL SORTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ACOUSTIC CELL SORTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ACOUSTIC CELL SORTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL FLUORESCENCE ACTIVATED CELL SORTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL FLUORESCENCE ACTIVATED CELL SORTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL FLUORESCENCE ACTIVATED CELL SORTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL IMAGING CELL SORTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL IMAGING CELL SORTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL IMAGING CELL SORTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MAGNETIC ACTIVATED CELL SORTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MAGNETIC ACTIVATED CELL SORTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MAGNETIC ACTIVATED CELL SORTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL COLUMN-BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL COLUMN-BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL COLUMN-BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL COLUMN-FREE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL COLUMN-FREE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL COLUMN-FREE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MICROFLUIDIC CELL SORTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MICROFLUIDIC CELL SORTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MICROFLUIDIC CELL SORTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SPECIALTY SORTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SPECIALTY SORTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL SPECIALTY SORTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL LASER CAPTURE MICRODISSECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL LASER CAPTURE MICRODISSECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL LASER CAPTURE MICRODISSECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL RAMAN-ACTIVATED SORTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL RAMAN-ACTIVATED SORTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL RAMAN-ACTIVATED SORTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CELL SORTING MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BLOOD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BLOOD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL BLOOD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL WHOLE BLOOD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL WHOLE BLOOD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL WHOLE BLOOD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMCS) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMCS) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMCS) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL BONE MARROW MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL BONE MARROW MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL BONE MARROW MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL SOLID TISSUE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL SOLID TISSUE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL SOLID TISSUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL TUMOR TISSUE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL TUMOR TISSUE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL TUMOR TISSUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL NORMAL TISSUE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL NORMAL TISSUE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL NORMAL TISSUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL CELL CULTURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL CELL CULTURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL PRIMARY CELLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL PRIMARY CELLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL PRIMARY CELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL CELL LINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL CELL LINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL CELL LINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ORGANOIDS AND SPHEROIDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ORGANOIDS AND SPHEROIDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ORGANOIDS AND SPHEROIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL MICROBIAL SAMPLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL MICROBIAL SAMPLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL MICROBIAL SAMPLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL BACTERIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL BACTERIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL BACTERIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL YEAST AND FUNGI MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL YEAST AND FUNGI MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL YEAST AND FUNGI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL CELL SORTING MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL LIFE SCIENCE RESEARCH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL LIFE SCIENCE RESEARCH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL LIFE SCIENCE RESEARCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL IMMUNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL IMMUNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL STEM CELL BIOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL STEM CELL BIOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL STEM CELL BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL NEUROSCIENCE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL NEUROSCIENCE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL NEUROSCIENCE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL IMMUNOPHENOTYPING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL IMMUNOPHENOTYPING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL IMMUNOPHENOTYPING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL HEMATOLOGIC MALIGNANCIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL HEMATOLOGIC MALIGNANCIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL HEMATOLOGIC MALIGNANCIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL IMMUNE MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL IMMUNE MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL IMMUNE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL CELL THERAPY AND REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL CELL THERAPY AND REGENERATIVE MEDICINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL CELL THERAPY AND REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL DRUG DISCOVERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL DRUG DISCOVERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL TARGET IDENTIFICATION AND VALIDATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL TARGET IDENTIFICATION AND VALIDATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL TARGET IDENTIFICATION AND VALIDATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL SCREENING AND LEAD OPTIMIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL SCREENING AND LEAD OPTIMIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL SCREENING AND LEAD OPTIMIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL SINGLE-CELL OMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL SINGLE-CELL OMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL SINGLE-CELL OMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL CELL SORTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL ACADEMIC AND RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL ACADEMIC AND RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL ACADEMIC AND RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL CELL SORTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC CELL SORTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC CELL SORTING MARKET SIZE, BY PRODUCT OFFERING, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC CELL SORTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC CELL SORTING MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC CELL SORTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC CELL SORTING MARKET SIZE, BY SORTING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC CELL SORTING MARKET SIZE, BY MAGNETIC ACTIVATED CELL SORTING, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC CELL SORTING MARKET SIZE, BY SPECIALTY SORTING, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC CELL SORTING MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC CELL SORTING MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC CELL SORTING MARKET SIZE, BY SOLID TISSUE, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC CELL SORTING MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC CELL SORTING MARKET SIZE, BY MICROBIAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC CELL SORTING MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC CELL SORTING MARKET SIZE, BY LIFE SCIENCE RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC CELL SORTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC CELL SORTING MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC CELL SORTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA CELL SORTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 198. NORTH AMERICA CELL SORTING MARKET SIZE, BY PRODUCT OFFERING, 2018-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA CELL SORTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 200. NORTH AMERICA CELL SORTING MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA CELL SORTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 202. NORTH AMERICA CELL SORTING MARKET SIZE, BY SORTING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA CELL SORTING MARKET SIZE, BY MAGNETIC ACTIVATED CELL SORTING, 2018-2032 (USD MILLION)
  • TABLE 204. NORTH AMERICA CELL SORTING MARKET SIZE, BY SPECIALTY SORTING, 2018-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA CELL SORTING MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 206. NORTH AMERICA CELL SORTING MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA CELL SORTING MARKET SIZE, BY SOLID TISSUE, 2018-2032 (USD MILLION)
  • TABLE 208. NORTH AMERICA CELL SORTING MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA CELL SORTING MARKET SIZE, BY MICROBIAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 210. NORTH AMERICA CELL SORTING MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA CELL SORTING MARKET SIZE, BY LIFE SCIENCE RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 212. NORTH AMERICA CELL SORTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA CELL SORTING MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 214. NORTH AMERICA CELL SORTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA CELL SORTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 216. LATIN AMERICA CELL SORTING MARKET SIZE, BY PRODUCT OFFERING, 2018-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA CELL SORTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 218. LATIN AMERICA CELL SORTING MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA CELL SORTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 220. LATIN AMERICA CELL SORTING MARKET SIZE, BY SORTING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA CELL SORTING MARKET SIZE, BY MAGNETIC ACTIVATED CELL SORTING, 2018-2032 (USD MILLION)
  • TABLE 222. LATIN AMERICA CELL SORTING MARKET SIZE, BY SPECIALTY SORTING, 2018-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA CELL SORTING MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 224. LATIN AMERICA CELL SORTING MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA CELL SORTING MARKET SIZE, BY SOLID TISSUE, 2018-2032 (USD MILLION)
  • TABLE 226. LATIN AMERICA CELL SORTING MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA CELL SORTING MARKET SIZE, BY MICROBIAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 228. LATIN AMERICA CELL SORTING MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA CELL SORTING MARKET SIZE, BY LIFE SCIENCE RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 230. LATIN AMERICA CELL SORTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA CELL SORTING MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 232. LATIN AMERICA CELL SORTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPE CELL SORTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPE CELL SORTING MARKET SIZE, BY PRODUCT OFFERING, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPE CELL SORTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPE CELL SORTING MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPE CELL SORTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPE CELL SORTING MARKET SIZE, BY SORTING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPE CELL SORTING MARKET SIZE, BY MAGNETIC ACTIVATED CELL SORTING, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPE CELL SORTING MARKET SIZE, BY SPECIALTY SORTING, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPE CELL SORTING MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPE CELL SORTING MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPE CELL SORTING MARKET SIZE, BY SOLID TISSUE, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPE CELL SORTING MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPE CELL SORTING MARKET SIZE, BY MICROBIAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPE CELL SORTING MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPE CELL SORTING MARKET SIZE, BY LIFE SCIENCE RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPE CELL SORTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPE CELL SORTING MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPE CELL SORTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST CELL SORTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 252. MIDDLE EAST CELL SORTING MARKET SIZE, BY PRODUCT OFFERING, 2018-2032 (USD MILLION)
  • TABLE 253. MIDDLE EAST CELL SORTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 254. MIDDLE EAST CELL SORTING MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 255. MIDDLE EAST CELL SORTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 256. MIDDLE EAST CELL SORTING MARKET SIZE, BY SORTING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 257. MIDDLE EAST CELL SORTING MARKET SIZE, BY MAGNETIC ACTIVATED CELL SORTING, 2018-2032 (USD MILLION)
  • TABLE 258. MIDDLE EAST CELL SORTING MARKET SIZE, BY SPECIALTY SORTING, 2018-2032 (USD MILLION)
  • TABLE 259. MIDDLE EAST CELL SORTING MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 260. MIDDLE EAST CELL SORTING MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 261. MIDDLE EAST CELL SORTING MARKET SIZE, BY SOLID TISSUE, 2018-2032 (USD MILLION)
  • TABLE 262. MIDDLE EAST CELL SORTING MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 263. MIDDLE EAST CELL SORTING MARKET SIZE, BY MICROBIAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 264. MIDDLE EAST CELL SORTING MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 265. MIDDLE EAST CELL SORTING MARKET SIZE, BY LIFE SCIENCE RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 266. MIDDLE EAST CELL SORTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 267. MIDDLE EAST CELL SORTING MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 268. MIDDLE EAST CELL SORTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 269. AFRICA CELL SORTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 270. AFRICA CELL SORTING MARKET SIZE, BY PRODUCT OFFERING, 2018-2032 (USD MILLION)
  • TABLE 271. AFRICA CELL SORTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 272. AFRICA CELL SORTING MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 273. AFRICA CELL SORTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 274. AFRICA CELL SORTING MARKET SIZE, BY SORTING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 275. AFRICA CELL SORTING MARKET SIZE, BY MAGNETIC ACTIVATED CELL SORTING, 2018-2032 (USD MILLION)
  • TABLE 276. AFRICA CELL SORTING MARKET SIZE, BY SPECIALTY SORTING, 2018-2032 (USD MILLION)
  • TABLE 277. AFRICA CELL SORTING MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 278. AFRICA CELL SORTING MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 279. AFRICA CELL SORTING MARKET SIZE, BY SOLID TISSUE, 2018-2032 (USD MILLION)
  • TABLE 280. AFRICA CELL SORTING MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 281. AFRICA CELL SORTING MARKET SIZE, BY MICROBIAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 282. AFRICA CELL SORTING MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 283. AFRICA CELL SORTING MARKET SIZE, BY LIFE SCIENCE RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 284. AFRICA CELL SORTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 285. AFRICA CELL SORTING MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 286. AFRICA CELL SORTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 287. GLOBAL CELL SORTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 288. ASEAN CELL SORTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 289. ASEAN CELL SORTING MARKET SIZE, BY PRODUCT OFFERING, 2018-2032 (USD MILLION)
  • TABLE 290. ASEAN CELL SORTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 291. ASEAN CELL SORTING MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 292. ASEAN CELL SORTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 293. ASEAN CELL SORTING MARKET SIZE, BY SORTING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 294. ASEAN CELL SORTING MARKET SIZE, BY MAGNETIC ACTIVATED CELL SORTING, 2018-2032 (USD MILLION)
  • TABLE 295. ASEAN CELL SORTING MARKET SIZE, BY SPECIALTY SORTING, 2018-2032 (USD MILLION)
  • TABLE 296. ASEAN CELL SORTING MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 297. ASEAN CELL SORTING MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 298. ASEAN CELL SORTING MARKET SIZE, BY SOLID TISSUE, 2018-2032 (USD MILLION)
  • TABLE 299. ASEAN CELL SORTING MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 300. ASEAN CELL SORTING MARKET SIZE, BY MICROBIAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 301. ASEAN CELL SORTING MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 302. ASEAN CELL SORTING MARKET SIZE, BY LIFE SCIENCE RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 303. ASEAN CELL SORTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 304. ASEAN CELL SORTING MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 305. ASEAN CELL SORTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 306. GCC CELL SORTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 307. GCC CELL SORTING MARKET SIZE, BY PRODUCT OFFERING, 2018-2032 (USD MILLION)
  • TABLE 308. GCC CELL SORTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 309. GCC CELL SORTING MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 310. GCC CELL SORTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 311. GCC CELL SORTING MARKET SIZE, BY SORTING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 312. GCC CELL SORTING MARKET SIZE, BY MAGNETIC ACTIVATED CELL SORTING, 2018-2032 (USD MILLION)
  • TABLE 313. GCC CELL SORTING MARKET SIZE, BY SPECIALTY SORTING, 2018-2032 (USD MILLION)
  • TABLE 314. GCC CELL SORTING MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 315. GCC CELL SORTING MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 316. GCC CELL SORTING MARKET SIZE, BY SOLID TISSUE, 2018-2032 (USD MILLION)
  • TABLE 317. GCC CELL SORTING MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 318. GCC CELL SORTING MARKET SIZE, BY MICROBIAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 319. GCC CELL SORTING MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 320. GCC CELL SORTING MARKET SIZE, BY LIFE SCIENCE RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 321. GCC CELL SORTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 322. GCC CELL SORTING MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 323. GCC CELL SORTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 324. EUROPEAN UNION CELL SORTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 325. EUROPEAN UNION CELL SORTING MARKET SIZE, BY PRODUCT OFFERING, 2018-2032 (USD MILLION)
  • TABLE 326. EUROPEAN UNION CELL SORTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 327. EUROPEAN UNION CELL SORTING MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 328. EUROPEAN UNION CELL SORTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 329. EUROPEAN UNION CELL SORTING MARKET SIZE, BY SORTING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 330. EUROPEAN UNION CELL SORTING MARKET SIZE, BY MAGNETIC ACTIVATED CELL SORTING, 2018-2032 (USD MILLION)
  • TABLE 331. EUROPEAN UNION CELL SORTING MARKET SIZE, BY SPECIALTY SORTING, 2018-2032 (USD MILLION)
  • TABLE 332. EUROPEAN UNION CELL SORTING MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 333. EUROPEAN UNION CELL SORTING MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 334. EUROPEAN UNION CELL SORTING MARKET SIZE, BY SOLID TISSUE, 2018-2032 (USD MILLION)
  • TABLE 335. EUROPEAN UNION CELL SORTING MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 336. EUROPEAN UNION CELL SORTING MARKET SIZE, BY MICROBIAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 337. EUROPEAN UNION CELL SORTING MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 338. EUROPEAN UNION CELL SORTING MARKET SIZE, BY LIFE SCIENCE RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 339. EUROPEAN UNION CELL SORTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 340. EUROPEAN UNION CELL SORTING MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 341. EUROPEAN UNION CELL SORTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 342. BRICS CELL SORTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 343. BRICS CELL SORTING MARKET SIZE, BY PRODUCT OFFERING, 2018-2032 (USD MILLION)
  • TABLE 344. BRICS CELL SORTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 345. BRICS CELL SORTING MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 346. BRICS CELL SORTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 347. BRICS CELL SORTING MARKET SIZE, BY SORTING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 348. BRICS CELL SORTING MARKET SIZE, BY MAGNETIC ACTIVATED CELL SORTING, 2018-2032 (USD MILLION)
  • TABLE 349. BRICS CELL SORTING MARKET SIZE, BY SPECIALTY SORTING, 2018-2032 (USD MILLION)
  • TABLE 350. BRICS CELL SORTING MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 351. BRICS CELL SORTING MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 352. BRICS CELL SORTING MARKET SIZE, BY SOLID TISSUE, 2018-2032 (USD MILLION)
  • TABLE 353. BRICS CELL SORTING MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 354. BRICS CELL SORTING MARKET SIZE, BY MICROBIAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 355. BRICS CELL SORTING MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 356. BRICS CELL SORTING MARKET SIZE, BY LIFE SCIENCE RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 357. BRICS CELL SORTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 358. BRICS CELL SORTING MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 359. BRICS CELL SORTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 360. G7 CELL SORTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 361. G7 CELL SORTING MARKET SIZE, BY PRODUCT OFFERING, 2018-2032 (USD MILLION)
  • TABLE 362. G7 CELL SORTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 363. G7 CELL SORTING MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 364. G7 CELL SORTING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 365. G7 CELL SORTING MARKET SIZE, BY SORTING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 366. G7 CELL SORTING MARKET SIZE, BY MAGNETIC ACTIVATED CELL SORTING, 2018-2032 (USD MILLION)
  • TABLE 367. G7 CELL SORTING MARKET SIZE, BY SPECIALTY SORTING, 2018-2032 (USD MILLION)
  • TABLE 368. G7 CELL SORTING MARKET SIZE, BY SAMPLE SOURCE, 2018-2032 (USD MILLION)
  • TABLE 369. G7 CELL SORTING MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 370. G7 CELL SORTING MARKET SIZE, BY SOLID TISSUE, 2018-2032 (USD MILLION)
  • TABLE 371. G7 CELL SORTING MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 372. G7 CELL SORTING MARKET SIZE, BY MICROBIAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 373. G7 CELL SORTING MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 374. G7 CELL SORTING MARKET SIZE, BY LIFE SCIENCE RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 375. G7 CELL SORTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018